Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Pharmacokinetics of Single Oral Dose of Vonoprazan 20 mg in Healthy Adult Males
jRCT2080223047Phase 3
- Sponsor
- Takeda
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vonoprazan in Peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD), sponsored by Takeda. Primary endpoint: Primary: Food effect on vonoprazan pharmacokinetics.
02
Drugs
vonoprazan
03
Conditions
Peptic ulcer disease (PUD)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on jRCT2080223047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223047.